| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.05. | Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma | 4 | CNW | ||
| 27.04. | Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences | 1 | CNW | ||
| 16.04. | Sona Nanotech Inc: Sona Nanotech appoints Smylie, Trites to advisory board | 1 | Stockwatch | ||
| 16.04. | Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board | 1 | CNW | ||
| 13.04. | Sona Nanotech Inc: Sona Nanotech upbeat about THT's effect on tumours | 2 | Stockwatch | ||
| 13.04. | Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies | 2 | CNW | ||
| 08.04. | Sona Nanotech Inc: Sona says THT shows strong combo cancer efficacy | 3 | Stockwatch | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 07.04. | Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study | 1 | CNW | ||
| 17.03. | Sona Nanotech Inc: Sona Nanotech to hold investor webinar March 18 | 3 | Stockwatch | ||
| 16.03. | Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study | 1 | CNW | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 686 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.189 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 25.08.25 | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 969 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 23.07.25 | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 885 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 07.07.25 | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 1.028 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06.25 | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 793 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 16.06.25 | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 723 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 20,100 | 0,00 % | Formycon: Online-Präsentation für Investoren am 08.06.2026 | Vor diesem Hintergrund veranstaltet mwb research am 08.06.2026 um 10:00 CEST einen Online-Roundtable mit Dr. Stefan Glombitza (CEO), Enno Spillner (CFO), Nicola Mikulcik (CBO) und Dr. Andreas Seidl... ► Artikel lesen | |
| OBDUCAT | 0,088 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| SOLESENCE | 1,200 | 0,00 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| RIBER | 13,680 | +0,74 % | Riber: Margen steigen, KI-Boom treibt - Hidden Champion vor nächsten Kursschub? | Hightech "Made in France" mit Rückenwind durch KI und Photoniks: Riber verbessert trotz leicht rückläufigem Umsatz deutlich seine Profitabilität und könnte vor einem neuen Wachstumszyklus stehen. Riber... ► Artikel lesen | |
| CANATU | 9,500 | 0,00 % | Canatu Oyj: Inside information: Canatu announces a leadership transition - Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen | Canatu Plc Inside information 11 May 2026 at 09:00 a.m. EEST
Inside information: Canatu announces a leadership transition - Dr. Maximilian Slawinski appointed as CEO and successor to Juha Kokkonen
Canatu's... ► Artikel lesen | |
| ONTO INNOVATION | 231,80 | -0,64 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| VEECO INSTRUMENTS | 53,50 | +1,02 % | Veeco Instruments Inc.: Veeco Announces $250 Million+ in Equipment Orders for Manufacturing Indium Phosphide Lasers | High-volume orders from multiple customers for its Spector, Lumina and Wet Processing Systems to drive strong growth. PLAINVIEW, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,202 | 0,00 % | Spotlight Stock Market: Market Notice 63/26 - Information regarding the rights issue from Smoltek Nanotech Holding AB | ||
| KOPIN | 4,686 | -1,14 % | Fabric.AI (Nasdaq: FABC) and Kopin Corporation (Nasdaq: KOPN) Appoint Bill Maffucci to Lead Development of Neural I/o MicroLED Optical Interconnect Chip Program | NEW YORK, NY, May 06, 2026 (GLOBE NEWSWIRE) -- Fabric.AI (Nasdaq: FABC) ("Fabric.AI" or "the Company"), an AI infrastructure company developing a suite of fabless semiconductor technologies for next-generation... ► Artikel lesen | |
| NANOVIRICIDES | 1,230 | -1,60 % | As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies | SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides... ► Artikel lesen | |
| NVE | 93,50 | +0,54 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| GOMSPACE | 1,679 | +0,06 % | GomSpace Group AB: Annual general meeting held in GomSpace Group AB (publ) | Today, the annual general meeting of 2026 has been held in GomSpace Group AB (publ) (the "Company" or "GomSpace"). Below follows a summary of the decisions taken by the annual general meeting (all... ► Artikel lesen | |
| GAUZY | 0,650 | +7,88 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| ACACIA RESEARCH | 3,920 | -0,51 % | Acacia Research Q1 2026 slides show mixed results, strong liquidity | ||
| ADVANCE ZINCTEK | 0,414 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky |